| Project/Area Number |
18590074
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Biological pharmacy
|
|---|
| Research Institution | Teikyo University |
|---|
Principal Investigator |
SUGIURA Takayuki Teikyo University, Fac. Pharm. Sci, Professor (40130009)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
YAMASHITA Atsushi Teikyo University, Fac. Pharm. Sci, Associate Professor (80230415)
|
|---|
| Project Period (FY) |
2006 – 2007
|
| Project Status |
Completed (Fiscal Year 2007)
|
| Budget Amount *help |
¥4,010,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥510,000)
Fiscal Year 2007: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2006: ¥1,800,000 (Direct Cost: ¥1,800,000)
|
|---|
| Keywords | cannabinoid / 2-arachidonoylglvicerol / anandamide / eosinophil / allergy / macrophage / natural killer / dendritic cell / 2-アラキドノイルグリセロール / モノアシルグリセロール / アレルギー / マリファナ / 抗炎症薬 / 脂質メディエーター / エイコサノイド |
|---|
| Research Abstract |
In this study, we first examined the roles of the CB2 receptor and 2-AG in allergic inflammation. We found that the level of 2-AG was dramatically augmented in the mouse ear with chronic contact dermatitis. Notably, treatment with SR144528, a CB2 receptor antagonist, markedly reduced allergic inflammation. These results strongly suggest that the CB2 receptor and its endogenous ligand 2-AG are closely involved in allergic inflammation.
We then examined the effect of 2-AG on eosinophils. We found that 2-AG augmented the adhesion of human eosinophils to endothelial cells. Interestingly, treatment of the endothelial cells with SR144528 abolished thrombin- or TNF-alpha- induced adhesion of eosinophils to endothelial cells. These results suggest that the CB2 and 2-AG are also involved in the pathogenesis of the vascular system.
Notably, 2-AG also induced the migration of dendritic cells. This observation suggests that 2-AG may be involved in the regulation of the immune responses.
Interestingly, the cytotoxic activity of natural killer cells was markedly augmented by CB2 receptor agonists such as CP55940 and 2-AG. This finding suggests that the CB2 receptor and its endogenous ligand 2-AG are involved in the regulation of cytotoxicity of natural killer cells and play some roles in the natural immunity.
We found that the phagocytic activity of macrophage-like cells was augmented following treat-ment of the cells with 2-AG, indicating that the CB2 receptor and its endogenous ligand 2-AG are also involved in the pathogenesis of inflammatory reactions in various mammalian tissues.
These results strongly suggest that the CB2 receptor and its endogenous ligand 2-AG are closely involved in various types of inflammatory reactions and immune responses in mammals.
|
